Clinical Trial Update: Identification of a Biomarker Predictive of Evolution of Parkinson Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from Nantes University Hospital is investigating a biomarker that may predict the progression of Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Nantes University Hospital | Conditions: Parkinson Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING